Damon Reed, MD, Pediatric Hematology & Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

DamonRReedMD

Pediatric Hematology & Oncology Tampa, FL

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Associate Member, Sarcoma and Department of Individualized Cancer Management, Moffitt Cancer Center. Adolescent and Young Adult Program Director

Overview of Dr. Reed

Dr. Damon Reed is a pediatric and AYA hematologist/oncologist in Tampa, FL at Moffitt Cancer Center. He is the leader of the National Pediatric Cancer Foundation's Sunshine Project, a Collaborative Clinical Trials and Translational Research consortium. He also is the Director of the AYA Oncology Program at Moffitt and the Vice Chair of the Bone Committee in the Children's Oncology Group. Additionally, he is affiliated with multiple hospitals in the area, including Johns Hopkins All Children's Hospital.

He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 13 years. He specializes in pediatric and AYA sarcoma oncology including but not limited to osteosarcoma, ewing sarcoma, soft tissue sarcomas, rhabdomyosarcoma and desmoid tumors.

Education & Training

  • St Jude Childrens Res Hospital
    St Jude Childrens Res HospitalFellowship, Pediatric Hematology/Oncology, 2005 - 2008
  • Boston Children's Hospital
    Boston Children's HospitalResidency, Pediatrics, 2002 - 2005
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2002

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2008 - 2022
  • TN State Medical License
    TN State Medical License 2005 - 2010
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • SP-2577 Granted Fast Track Designation by the FDA for Patients with Ewing Sarcoma
    SP-2577 Granted Fast Track Designation by the FDA for Patients with Ewing SarcomaDecember 16th, 2019
  • Shortage of Critical Cancer Drug Forcing Some Children to Go Without
    Shortage of Critical Cancer Drug Forcing Some Children to Go WithoutOctober 21st, 2019
  • Case Report NTRK-1 Fusion in Endocervical Fibroblastic Malignant Peripheral Nerve Sheath Tumor Marking Eligibility for Larotrectinib Therapy: A Case Report
    Case Report NTRK-1 Fusion in Endocervical Fibroblastic Malignant Peripheral Nerve Sheath Tumor Marking Eligibility for Larotrectinib Therapy: A Case ReportMay 23rd, 2019
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AvMed Health Open Access
    BCBS Blue Card PPO
    BCBS California CaliforniaCare HMO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    BCBS Illinois PPO
    Blue Shield California HMO
    Blue Shield California PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Florida - Employer Group PPO
    First Health PPO
    Great West PPO
    Health Net California Large Group PPO
    Health Net HMO - Employer Group
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PHCS PPO - Kaiser
    Multiplan PPO
    Pacificare HMO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    Wellmark Alliance Select
  • Please verify your coverage with the provider's office directly when scheduling an appointment